Skip to main content

Table 3 Pre- and postoperative hemodynamic data (cMRI)

From: Right ventricular remodeling after conduit replacement in patients with corrected tetralogy of Fallot - evaluation by cardiac magnetic resonance

Variables (n = 10)

Before PVR

After PVR

Students t-test

Wilcoxon Signed Rank Test

RVEDV (ml)

309 ± 85

231 ± 45

0.001

0.005

RVEDVI (ml/m2)

161 ± 33

120 ± 23

< 0.001

0.005

RVESV (ml)

171 ± 58

136 ± 40

0.043

0.047

RVESVI (ml/m2)

89 ± 25

71 ± 21

0.036

0.047

RVSV (ml)

138 ± 45

95 ± 13

0.006

0.005

RVSVI (ml/m2)

72 ± 20

50 ± 6

0.002

0.005

RVEF (%)

46 ± 11

42 ± 9

0.337

0.373

LVEDV (ml)

149 ± 22

171 ± 28

0.002

0.007

LVEDVI (ml/m2)

79 ± 10

90 ± 15

0.012

0.015

LVESV (ml)

68 ± 17

76 ± 20

0.213

0.236

LVESVI (ml/m2)

36 ± 8

40 ± 11

0.271

0.284

LVSV (ml)

81 ± 12

95 ± 12

< 0.001

0.005

LVSVI (ml/m2)

43 ± 7

50 ± 6

0.001

0.005

LVEF (%)

55 ± 7

56 ± 6

0.656

0.593

PI (%)

49 ± 11

1 ± 1

< 0.001

NA

MPA netflow (mL/min)

5100 ± 1500

6100 ± 800

0.120

0.139

  1. Values are expressed as number (%) or mean ± SD (median, range); EF, ejection fraction; RVEDV, right ventricular end-diastolic volume; RVESV, right ventricular end-systolic volume; RVSV, right ventricular stroke volume; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVSV, left ventricular stroke volume; PI, pulmonary insufficiency; MPA, main pulmonary artery